You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
412 FIRST STREET SE
SUITE 100
WASHINGTON DC 20003
USA
On behalf of: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA (reported on 2009-03-31)
Received: $60000
Agency: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
Filed under: Medicare / Medicaid, see top firms.
MONITOR FEDERAL LEGISLATION RELATED TO MEDICARE AND OTHER HEALTH CARE ISSUES AND ADVISE CLIENT AS IT AFFECTS THEM. IN ADDITION, PATENT REFORM ACT OF 2009 (H.R.1260/ S.515/S.610), BUDGET RESOLUTION FY2010 (BILL NUMBER HAS NOT YET BEEN ASSIGNED), PATHWAY FOR BIOSIMILARS ACT (H.R. 1548) & AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 (HR1) AS IT RELATES TO COMPARATIVE EFFECTIVENESS RESEARCH FUNDING.. HEALTH CARE REFORM LEGISLATION (TO DATE NO SPECIFIC BILLS HAVE BEEN INTRODUCED).
PHARMACEUTICAL IMPORT SAFETY LEGISLATION.
Lobbyist(s): DARREN WILLCOX
Agency: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
Filed under: Health Issues, see top firms.
MONITOR FEDERAL LEGISLATION RELATED TO MEDICARE AND OTHER HEALTH CARE ISSUES AND ADVISE CLIENT AS IT AFFECTS THEM. IN ADDITION, PATENT REFORM ACT OF 2009 (H.R.1260/ S.515/S.610), BUDGET RESOLUTION FY2010 (BILL NUMBER HAS NOT YET BEEN ASSIGNED), PATHWAY FOR BIOSIMILARS ACT (H.R. 1548) & AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 (HR1) AS IT RELATES TO COMPARATIVE EFFECTIVENESS RESEARCH FUNDING.. HEALTH CARE REFORM LEGISLATION (TO DATE NO SPECIFIC BILLS HAVE BEEN INTRODUCED).
PHARMACEUTICAL IMPORT SAFETY LEGISLATION.
Lobbyist(s): DARREN WILLCOX
Agency: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Commerce - Dept of (DOC),
Filed under: Copyright / Patent / Trademark, see top firms.
MONITOR FEDERAL LEGISLATION RELATED TO HEALTH CARE IP ISSUES AND ADVISE CLIENT AS IT AFFECTS THEM. IN ADDITION, PATENT REFORM ACT OF 2009 (H.R.1260/ S.515/S.610), BUDGET RESOLUTION FY2010 (BILL NUMBER HAS NOT YET BEEN ASSIGNED), PATHWAY FOR BIOSIMILARS ACT (H.R. 1548) & AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 (HR1) AS IT RELATES TO COMPARATIVE EFFECTIVENESS RESEARCH FUNDING.. HEALTH CARE REFORM LEGISLATION (TO DATE NO SPECIFIC BILLS HAVE BEEN INTRODUCED).
PHARMACEUTICAL IMPORT SAFETY LEGISLATION.
Lobbyist(s): DARREN WILLCOX